00:00The CAR-T revolution could bring significant benefit to patients with various types of kidney disease.
00:06We can take advantage of the fact that there is a long haematological experience in this sense,
00:14after which it was seen that even some pathologies, from rheumatological pathologies to immunological pathologies
00:20that affect the kidney, can be managed with this type of therapy.
00:25We are certainly in the preliminary stages at this time, but we have several patients who are not responding to current therapies.
00:34and therefore in these cases we can apply this cutting-edge therapy, which will certainly see development in the coming years
00:40also because the procedures that must be implemented for their practical application will gradually be simplified.
